SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-046197
Filing Date
2023-04-17
Accepted
2023-04-17 16:14:49
Documents
13
Period of Report
2023-04-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm239540d3_8k.htm   iXBRL 8-K 35760
2 EXHIBIT 10.1 tm239540d3_ex10-1.htm EX-10.1 19249
  Complete submission text file 0001104659-23-046197.txt   236275

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ipsc-20230411.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipsc-20230411_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipsc-20230411_pre.xml EX-101.PRE 22597
7 EXTRACTED XBRL INSTANCE DOCUMENT tm239540d3_8k_htm.xml XML 3606
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40498 | Film No.: 23824113
SIC: 2836 Biological Products, (No Diagnostic Substances)